MedTrace Logo

Morbidity in Newly Diagnosed type2 Diabetes in Adults

NCT02002091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 327

Last updated 2024-06-21

Study results available
· View outcomes & findings →

Summary

* It is a prospective,observational, cohort study
* The main purpose of the study is to assess the prevalence of diabetic chronic complications in newly diagnosed type 2 diabetics in suburban area of Algiers.
* The secondary purpose is to study the impact of diabetic renal complications as a risk factor on the atherothrombotic events.

Conditions

  • Type2 Diabetes Mellitus
  • Complications

Interventions

OTHER

no specific treatment

lifestyle counseling, antihypertensive drugs, antidiabetic drugs (oral and / or insulin)treatment of comorbidity or complications of diabetes.

Sponsors & Collaborators

  • National Institute of public Health, Algeria

    collaborator UNKNOWN

  • Hopital Ain Taya

    collaborator OTHER

  • Parnet Hospital

    collaborator OTHER

  • Hôpital Mustapha Pacha

    collaborator OTHER

  • Birtraria Hospital

    collaborator OTHER

  • Bab El Oued Teaching Hospital

    collaborator OTHER

  • University of Algiers

    lead OTHER

Principal Investigators

  • Ahmed Biad, professor · University of Algiers -Faculté de Medecine-

  • Wafia-Nadia Nibouche- Hattab, Ass-Prof · University of Algiers -Faculté de Médecine-

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2013-12-31
Completion
2014-12-31

Countries

  • Algeria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02002091 on ClinicalTrials.gov